Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
Top Cited Papers
- 1 June 2004
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 363 (9426), 2049-2051
- https://doi.org/10.1016/s0140-6736(04)16456-8
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Cardiovascular prevention and blood pressure reductionJournal Of Hypertension, 2003
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJama-Journal Of The American Medical Association, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Comparative angiotensin II receptor blockade in healthy volunteers: The importance of dosingClinical Pharmacology & Therapeutics, 2002
- The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and DesignBlood Pressure, 1998